No images? Click here
25 April 2024
Malaria disproportionately affects those in situations of greatest poverty and vulnerability, with young children in Africa suffering the greatest mortality. Pregnant women, refugees and migrants are among the other groups at higher risk of contracting the disease. On World Malaria Day 2024, WHO is turning a spotlight on barriers to health equity, gender equality and human rights that compromise malaria responses worldwide – as well as concrete measures to overcome them.
Message from the Global Malaria Programme Director | World Malaria Day campaign
Ahead of World Malaria Day, the WHO Global Malaria Programme unveiled a new operational strategy outlining its priorities and key activities for the period 2024-2030. The strategy includes four strategic areas of focus: norms and standards, new tools and innovation, strategic information for impact, and technical leadership of the global malaria response.
Read the new operational strategy | Global technical strategy for malaria 2016-2030
Malaria in pregnancy is associated with adverse outcomes for both the mother and infant. A new publication from WHO presents an evidence review on the effects and safety of artemisinin and non-artemisinin antimalarial medicines during the first trimester of pregnancy.
A new report from WHO describes the history of malaria in Sri Lanka and the strategy undertaken to eliminate the disease nationwide, as well as policies to prevent its re-establishment. The report highlights challenges, lessons learned and essential elements for sustaining a malaria-free status.
About one third of the global population is at risk of contracting Plasmodium vivax malaria. Relapsing malaria caused by P. vivax malaria parasites poses a significant challenge to global malaria elimination efforts. To help guide research in this area, WHO has developed two preferred product characteristics (PPCs) to detect the risk of P. vivax relapse.
MPAG provides independent, strategic advice to WHO on all technical areas relating to malaria control and elimination. From 30 October to 1 November 2023, the group reviewed updates on subnational tailoring of interventions, antimalarial drug resistance in Africa, the Mekong Malaria Elimination programme, and the status of malaria vaccine roll-out, among other topics.
French and Portuguese translation of the manual and SOPs on insecticide resistance
- Manual for monitoring insecticide resistance in mosquito vectors and selecting appropriate interventions: French (only)
- SOP for testing insecticide susceptibility of adult mosquitoes in WHO bottle bioassays: French| Portuguese
- SOP for testing insecticide susceptibility of adult mosquitoes in WHO tube tests: French| Portuguese
- SOP for evaluating the sterilizing properties of pyriproxyfen in adult female mosquitoes in WHO bottle bioassays: French| Portuguese
- SOP for impregnation of filter papers for testing insecticide susceptibility of adult mosquitoes in WHO tube tests: French| Portuguese
- SOP for determining the ability of PBO to restore susceptibility of adult mosquitoes to pyrethroid insecticides in WHO tube tests: French| Portuguese
